Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Rules Needed To Classify mHealth Products, Says Industry Coalition

This article was originally published in The Gray Sheet

Executive Summary

FDA needs new regulations to establish product classifications for mobile health accessories and software applications that do not fall within existing agency rules, a mobile health industry group urged in a draft proposal document issued Sept. 29.

You may also be interested in...



FDA Must Consider UDI Rule’s Impact On mHealth, Coalition Cautions

In response to an FDA proposal that would require unique device identifiers to improve post-market surveillance of medical technologies, the mHealth Regulatory Coalition argues that most mobile health apps should fall under exceptions to the rule.

Digital Health In Brief

Virtual Health chooses Intel-GE Care Innovations Guide platform

Digital Health In Brief

Virtual Health chooses Intel-GE Care Innovations Guide platform

Related Content

Topics

UsernamePublicRestriction

Register

MT030591

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel